Trials / Completed
CompletedNCT06344767
Positive ER Expression Assessed by 18F-FES PET/CT in the MBC with ER-negative Primary Tumor
Positive Estrogen Receptor (ER) Expression Assessed by 18F-fluoroestradiol Positron Emission Tomography/Computed Tomography (18F-FES PET/CT) in the Metastatic Breast Cancer (MBC) with ER- Negative Primary Tumor
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 19 (actual)
- Sponsor
- Fudan University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the treatment pattern and efficacy of patients with negative primary ER lesion but positive ER expression in MBC using a novel convenient way of 18F-fluoroestradiol positron emission tomography/computed tomography (18F-FES PET/CT).
Conditions
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2024-05-05
- Completion
- 2024-05-05
- First posted
- 2024-04-03
- Last updated
- 2024-10-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06344767. Inclusion in this directory is not an endorsement.